(Q46366473)

English

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

author name string

Novitzky N

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Mohamed R

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Finlayson J

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

du Toit C

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

publication date

1 August 2000

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Experimental Hematology

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

28

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

941-949

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating erythropoietin in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditions controlling the proliferation of haemopoietic stem cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stromal abnormalities in neoplastic bone marrow diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic growth factor therapy of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cryopreservation of the bone marrow from patients with acute myeloid leukaemia leads to functional abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New treatment approaches for myelodysplastic syndrome and secondary leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antilymphocyte globulin for myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900489-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-472X(00)00489-6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/10989195

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46366473&oldid=2108190224"